Gladell P Paner

6PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer diagnosisLiquid biopsiesOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 29, 2026
Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma.

|Jan 31, 2024
The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men.

Dayana Delgado, Marc Gillard, Lin Tong

|May 01, 2023
Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists' Perspective.

Ming Zhou, Gladell P Paner

|Apr 26, 2022
Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice.

Gladell P Paner, Steven C Smith, Arndt Hartmann

|Mar 30, 2021
Seminal vesicle cystadenoma with dysplasia: missing link to adenocarcinoma?

Vaibhav Chumbalkar, Gregory Zagaja, Rodolfo Montironi

|Jan 12, 2021
Should Grade Group 1 (GG1) be called cancer?

Craig V Labbate, Gladell P Paner, Scott E Eggener

Pageof 1

Frequent Collaborators

1 joint publications

Craig V Labbate

1 joint publications

Scott E Eggener

1 joint publications

Steven C Smith

1 joint publications

Ming Zhou